| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.18 | 3e-05 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.18 | 5e-05 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |